Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
Cacciatore, I., et al., Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems
Are there known harmful side-effects
It's a key component in the function of ATP, the energy currency of our bodies
A dedicated team of American researchers and clinicians designed this advanced solution after years of in-depth research into obesity, brain function, and whole-body metabolic balance
US$ 23.83
US$ 27.54
US$ 21.35
US$ 21.77
US$ 24.44
US$ 23.11
US$ 28.98
US$ 28.26
